Medtronic CFO Gary Ellis has explained to investors that the medical device maker isn't making a strategic shift away from group purchasing organizations, despite the recent cancellation of several contracts with Premier and Novation. "There's a lot of speculation around here that a strategic change is going on," Ellis told analysts at the Barclay's Capital Investors Conference in Miami. "That is not the case." News